Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
ACC Vice President Cathie Biga discusses OBLs and ASCs during the ACC23 meeting. #ACC #OBLs #ASCs #ACC23

What the rise of outpatient cardiac OBLs and ASCs means for cardiology

To reduce the healthcare costs associated with straightforward, minimally invasive cardiovascular procedures, more and more ambulatory surgical centers and office based labs are opening all over the United States.

ACC Vice President Cathie Biga explains issues with cardiology reimbursements at ACC23. #ACC #ACC23

Reimbursement challenges raising concerns in cardiology

Cathie Biga, vice president of the American College of Cardiology, spoke to Cardiovascular Business at ACC.23 about challenges in the world of cardiology reimbursements. "As that healthcare dollar goes up, it is not going to the physicians," she said.

Thumbnail

Lawsuit blames teen’s death during flight on defibrillator issue, lack of training

A teenager went into cardiac arrest on an American Airlines flight from Honduras to Miami. He never recovered, and now his family has filed a new lawsuit that blames the airline.

money dollars payment counting

Cardiologists received $1.1B in industry payments in 6 years

Diving deeper into the data, researchers noted that 40.8% of the payments were tied to speaker fees. Another 19% were from consulting fees.

healthcare value value-based care money dollar

Startup focused on heart failure monitoring raises $25M with help from Novo Holdings, Medtronic

The round was led by two new investors, Novo Holdings and Andera Partners. Several existing investors, including Medtronic, also participated.

Cathie Biga, vice president of the American College of Cardiology (ACC) and president and CEO of Cardiovascular Management of Illinois, explains how ACC is becoming more involved in the business side of cardiology. She spoke in several sessions at the ACC 2023 meeting on cardiology business management topics. She brings her cardiac business management experience to ACC as the first non-clinician to take on a senior leadership role in the college. #ACC #ACC23

ACC plans to focus more on cardiology's business management issues

American College of Cardiology Vice President Cathie Biga spoke to Cardiovascular Business about why the organization wants to get more involved in the business side of cardiology.

venture capital corporate suit business corporatization

Medtronic, Edwards among the healthcare organizations chosen as World’s Most Ethical Companies in 2023

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

Thumbnail

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Displaying 281 - 288 of 1699

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.